A carregar...

Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer

The emergence of resistance to epidermal growth factor receptor (EGFR) inhibitor therapy is a major clinical problem for patients with non-small cell lung cancer (NSCLC). The mechanisms underlying tumor resistance to inhibitors of the kinase activity of EGFR are not fully understood. Here we found t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Rui, Hu, Zhongliang, Sun, Shi-Yong, Chen, Zhuo G., Owonikoko, Taofeek K., Sica, Gabriel L., Ramalingam, Suresh S., Curran, Walter J., Khuri, Fadlo R., Deng, Xingming
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3795834/
https://ncbi.nlm.nih.gov/pubmed/23894143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0095
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!